Skip to main content
Year archive

Anteris Technologies Global Corp. — 2025 filings

All 175 regulatory filings released by Anteris Technologies Global Corp. (AVR) in 2025, sourced directly from the official regulator.

175 Filings
2025 Period
2025 filings (175)
Filing Released Lang
Change of Director's Interest Notice 9 pages 263.4KB
Director's Dealing
2025-12-23 English
Notification regarding unquoted securities - AVR 6 pages 19.2KB
Share Issue/Capital Change
2025-12-23 English
Application for quotation of securities - AVR 6 pages 19.1KB
Share Issue/Capital Change
2025-12-23 English
FORM 4
Director's Dealing
2025-12-19 English
FORM 4
Director's Dealing
2025-12-19 English
FORM 4
Director's Dealing
2025-12-19 English
FORM 4
Director's Dealing
2025-12-19 English
424B3
Board/Management Information
2025-12-17 English
Final Director's Interest Notice 2 pages 239.6KB
Director's Dealing
2025-12-17 English
8-K
Board/Management Information
2025-12-15 English
Board Resignation 2 pages 171.8KB
Board/Management Information
2025-12-14 English
Regulatory Filings 2025
Regulatory Filings
2025-12-12 English
424B3
Capital/Financing Update
2025-12-11 English
Notification regarding unquoted securities - AVR 6 pages 19.8KB
Share Issue/Capital Change
2025-12-11 English
Notification regarding unquoted securities - AVR 8 pages 27.6KB
Share Issue/Capital Change
2025-12-10 English
Change of Director's Interest Notice 13 pages 301.3KB
Director's Dealing
2025-12-10 English
FORM 4
Director's Dealing
2025-12-08 English
FORM 4
Director's Dealing
2025-12-06 English
FORM 4
Director's Dealing
2025-12-06 English
FORM 4
Director's Dealing
2025-12-06 English
FORM 4
Director's Dealing
2025-12-06 English
Statement of CDIs on issue - AVR 3 pages 12.9KB
Regulatory Filings
2025-12-04 English
8-K
Declaration of Voting Results & Voting Rights Announcements
2025-12-04 English
Pause in Trading 1 page 116.4KB
Regulatory Filings
2025-12-03 English
Annual Meeting CEO Presentation 59 pages 5.0MB
Regulatory Filings
2025-12-03 English
Results of Meeting 4 pages 261.6KB
Declaration of Voting Results & Voting Rights Announcements
2025-12-03 English
Notification of cessation of securities - AVR 6 pages 20.2KB
Regulatory Filings
2025-12-02 English
8-K
Regulatory Filings
2025-12-01 English
Termination of Agreement 4 pages 618.9KB
Regulatory Filings
2025-12-01 English
S-1
Capital/Financing Update
2025-11-26 English
SEC Form S-1 Registration Statement 43 pages 933.6KB
Capital/Financing Update
2025-11-26 English
8-K
Regulatory Filings
2025-11-17 English
AVR Presents Data from 100 DurAVR THV Patients 3 pages 205.5KB
Regulatory Filings
2025-11-16 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-14 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-13 English
8-K
Regulatory Filings
2025-11-12 English
10-Q
Interim / Quarterly Report Q3 2025
2025-11-12 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-12 English
Quarterly Results Announcement and SEC Form 10-Q 86 pages 1.1MB
Interim / Quarterly Report Q3 2025
2025-11-12 English
Results for the Third Quarter of 2025 3 pages 249.2KB
Interim / Quarterly Report Q3 2025
2025-11-12 English
DEF 14A
Proxy Solicitation & Information Statement
2025-11-10 English
ARS
Annual Report
2025-11-10 English
Notice of General Meeting/Proxy Form 250 pages 5.0MB
Proxy Solicitation & Information Statement
2025-11-10 English
Regulatory Filings 2025
Regulatory Filings
2025-11-07 English
Statement of CDIs on issue - AVR 3 pages 12.9KB
Regulatory Filings
2025-11-05 English
Application for quotation of securities - AVR 6 pages 18.6KB
Share Issue/Capital Change
2025-11-05 English
Notification regarding unquoted securities - AVR 7 pages 21.6KB
Share Issue/Capital Change
2025-11-05 English
Cleansing Notice 2 pages 205.6KB
Capital/Financing Update
2025-11-05 English
8-K
Regulatory Filings
2025-11-03 English
FDA Approves DurAVR THV Global Pivotal Trial 2 pages 225.3KB
Regulatory Filings
2025-11-02 English
Update on Capital Raising Timetable 2 pages 245.2KB
Capital/Financing Update
2025-11-02 English
Notification of cessation of securities - AVR 4 pages 14.8KB
Share Issue/Capital Change
2025-11-02 English
PRE 14A
Proxy Solicitation & Information Statement
2025-10-30 English
Schedule 14A Preliminary Proxy Statement 71 pages 2.3MB
Proxy Solicitation & Information Statement
2025-10-30 English
Cleansing Notice 2 pages 180.1KB
Capital/Financing Update
2025-10-29 English
Favorable Hemodynamics in Small Annuli Patients at One Year 2 pages 225.5KB
Regulatory Filings
2025-10-28 English
Application for quotation of securities - AVR 6 pages 18.3KB
Share Issue/Capital Change
2025-10-28 English
Notification regarding unquoted securities - AVR 7 pages 21.9KB
Share Issue/Capital Change
2025-10-28 English
8-K
Regulatory Filings
2025-10-28 English
8-K
Capital/Financing Update
2025-10-27 English
First Patients Treated in DurAVR THV Global Pivotal Trial 2 pages 219.0KB
Regulatory Filings
2025-10-27 English
Suspension from Quotation 2 pages 291.9KB
Regulatory Filings
2025-10-27 English
Capital Raise to Advance PARADIGM Trial & Commercialisation 42 pages 5.6MB
Regulatory Filings
2025-10-27 English
Proposed issue of securities - AVR 9 pages 30.7KB
Capital/Financing Update
2025-10-27 English
Reinstatement to Quotation 1 page 113.8KB
Regulatory Filings
2025-10-27 English
8-K
Capital/Financing Update
2025-10-24 English
Trading Halt 2 pages 226.3KB
Capital/Financing Update
2025-10-23 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-10-18 English
8-K
Regulatory Filings
2025-10-15 English
8-K
Regulatory Filings
2025-10-15 English
First European Regulatory Clearance For DurAVR Global Trial 3 pages 234.3KB
Regulatory Filings
2025-10-15 English
Annual Meeting Announcement 2 pages 175.7KB
Proxy Solicitation & Information Statement
2025-10-15 English
Statement of CDIs on issue - AVR 3 pages 12.9KB
Regulatory Filings
2025-10-01 English
8-K
Declaration of Voting Results & Voting Rights Announcements
2025-09-29 English
Results of Special Meeting and PARADIGM Trial Update 2 pages 209.4KB
Declaration of Voting Results & Voting Rights Announcements
2025-09-29 English
Notification of cessation of securities - AVR 9 pages 27.8KB
Regulatory Filings
2025-09-29 English
DEFA14A
Proxy Solicitation & Information Statement
2025-09-19 English
8-K
Regulatory Filings
2025-09-19 English
Special Meeting - Adjourned 1 page 152.5KB
Regulatory Filings
2025-09-18 English
Adjournment of Special Meeting of Stockholders - Update 3 pages 184.1KB
Regulatory Filings
2025-09-18 English
Postponement of Special Meeting - Update 3 pages 184.6KB
Regulatory Filings
2025-09-11 English
DEFA14A
Proxy Solicitation & Information Statement
2025-09-11 English
8-K
Regulatory Filings
2025-09-11 English
Notification regarding unquoted securities - AVR 7 pages 21.4KB
Share Issue/Capital Change
2025-09-07 English
DEFA14A
Proxy Solicitation & Information Statement
2025-09-04 English
8-K
Regulatory Filings
2025-09-04 English
Postponement of Special Meeting 3 pages 184.8KB
Proxy Solicitation & Information Statement
2025-09-03 English
Statement of CDIs on issue - AVR 3 pages 13.3KB
Share Issue/Capital Change
2025-09-03 English
Notification of cessation of securities - AVR 7 pages 22.0KB
Regulatory Filings
2025-09-01 English
Definitive Proxy Statement 24 pages 621.9KB
Proxy Solicitation & Information Statement
2025-08-18 English
DEF 14A
Proxy Solicitation & Information Statement
2025-08-18 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-08-14 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-08-13 English
8-K
Interim / Quarterly Report Q2 2025
2025-08-12 English
10-Q
Interim / Quarterly Report Q2 2025
2025-08-11 English
Quarterly Results Announcement and SEC Form 10-Q 42 pages 989.6KB
Interim / Quarterly Report Q2 2025
2025-08-11 English
Results for the Second Quarter of 2025 3 pages 285.8KB
Interim / Quarterly Report Q2 2025
2025-08-11 English
Preliminary Proxy Statement 22 pages 370.7KB
Proxy Solicitation & Information Statement
2025-08-10 English
PRE 14A
Proxy Solicitation & Information Statement
2025-08-08 English
8-K
Capital/Financing Update
2025-08-07 English
Waiver from ASX Listing Rule 7.1 2 pages 183.5KB
Regulatory Filings
2025-08-06 English
Statement of CDIs on issue - AVR 3 pages 12.9KB
Major Shareholding Notification
2025-08-05 English
Notification of cessation of securities - AVR 4 pages 15.4KB
Regulatory Filings
2025-08-03 English
8-K
Regulatory Filings
2025-07-29 English
Entry into a Material Definitive Agreement 4 pages 618.0KB
Regulatory Filings
2025-07-29 English
Notification regarding unquoted securities - AVR 6 pages 18.7KB
Share Issue/Capital Change
2025-07-13 English
Statement of CDIs on issue - AVR 3 pages 12.9KB
Share Issue/Capital Change
2025-07-02 English
Notification of cessation of securities - AVR 8 pages 24.3KB
Regulatory Filings
2025-07-02 English
FORM 3
Director's Dealing
2025-06-10 English
FORM 3
Director's Dealing
2025-06-10 English
Board Appointments 3 pages 223.2KB
Board/Management Information
2025-06-09 English
Final Director's Interest Notice 2 pages 244.5KB
Director's Dealing
2025-06-09 English
Initial Director's Interest Notice 4 pages 189.3KB
Director's Dealing
2025-06-09 English
8-K
Board/Management Information
2025-06-09 English
Statement of CDIs on issue - AVR 5 pages 19.1KB
Regulatory Filings
2025-06-05 English
Change of Director's Interest Notice 3 pages 307.4KB
Director's Dealing
2025-06-04 English
Notification of cessation of securities - AVR 5 pages 17.1KB
Regulatory Filings
2025-06-04 English
Notification regarding unquoted securities - AVR 8 pages 21.5KB
Share Issue/Capital Change
2025-05-15 English
8-K
Regulatory Filings
2025-05-14 English
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D)
Interim / Quarterly Report Q1 2025
2025-05-13 English
Quarterly Results Announcement and SEC Form 10-Q 36 pages 615.7KB
Interim / Quarterly Report Q1 2025
2025-05-13 English
Results for the First Quarter of 2025 5 pages 293.6KB
Interim / Quarterly Report Q1 2025
2025-05-13 English
Statement of CDIs on issue - AVR 5 pages 19.1KB
Share Issue/Capital Change
2025-05-06 English
10-K/A
Annual Report FY 2024
2025-04-29 English
SEC Form 10-K/A 34 pages 501.7KB
Annual Report FY 2024
2025-04-29 English
Notification of cessation of securities - AVR 5 pages 17.1KB
Share Issue/Capital Change
2025-04-28 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-04-08 English
Notification of cessation of securities - AVR 6 pages 20.0KB
Regulatory Filings
2025-04-06 English
Application for quotation of securities - AVR 9 pages 24.1KB
Share Issue/Capital Change
2025-04-06 English
Statement of CDIs on issue - AVR 5 pages 19.5KB
Regulatory Filings
2025-04-01 English
8-K
Regulatory Filings
2025-03-31 English
Clinical Milestone - 100 patients treated with DurAVR THV 2 pages 213.1KB
Regulatory Filings
2025-03-30 English
Notification regarding unquoted securities - AVR 8 pages 22.0KB
Share Issue/Capital Change
2025-03-26 English
Application for quotation of securities - AVR 11 pages 30.8KB
Share Issue/Capital Change
2025-03-26 English
Cleansing Notice 2 pages 217.2KB
Share Issue/Capital Change
2025-03-26 English
FORM 4/A
Director's Dealing
2025-03-21 English
FORM 4/A
Director's Dealing
2025-03-21 English
FORM 4/A
Director's Dealing
2025-03-21 English
FORM 4
Director's Dealing
2025-03-21 English
FORM 4
Director's Dealing
2025-03-21 English
FORM 4
Director's Dealing
2025-03-21 English
8-K
Regulatory Filings
2025-03-21 English
Anteris Reports One-Year Patient Outcomes for DurAVR THV 2 pages 277.3KB
Regulatory Filings
2025-03-20 English
Change of Directors' Interest Notice 9 pages 385.1KB
Director's Dealing
2025-03-20 English
8-K
Report Publication Announcement
2025-03-12 English
10-K
Annual Report FY 2024
2025-03-12 English
Annual Report to shareholders 192 pages 1.6MB
Annual Report FY 2024
2025-03-12 English
2024 Financial Results and Corporate Update 4 pages 322.2KB
Earnings Release FY 2024
2025-03-12 English
Corporate Governance Statement and Appendix 4G 26 pages 620.0KB
Governance Information
2025-03-12 English
Cleansing Notice 2 pages 241.6KB
Capital/Financing Update
2025-03-10 English
8-K
Board/Management Information
2025-03-06 English
Initial Director's Interest Notice 2 pages 270.8KB
Director's Dealing
2025-03-06 English
Director Appointment/Resignation 3 pages 229.5KB
Board/Management Information
2025-03-05 English
Application for quotation of securities - AVR 8 pages 21.1KB
Share Issue/Capital Change
2025-03-04 English
Statement of CDIs on issue - AVR 5 pages 19.5KB
Regulatory Filings
2025-03-04 English
ASX waiver from requirement to lodge an Appendix 4E 2 pages 189.7KB
Regulatory Filings
2025-02-27 English
Notification of cessation of securities - AVR 6 pages 19.8KB
Regulatory Filings
2025-02-17 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-02-14 English
Release of Australian Taxation Office Class Rulings 2 pages 156.5KB
Regulatory Filings
2025-02-12 English
Application for quotation of securities - AVR 9 pages 24.1KB
Capital/Financing Update
2025-02-11 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-02-10 English
Statement of CDIs on issue - AVR 5 pages 19.6KB
Regulatory Filings
2025-02-02 English
Director's Dealing 2025
Director's Dealing
2025-01-24 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-01-24 English
Cleansing Notice 2 pages 196.6KB
Regulatory Filings
2025-01-15 English
FORM 8-K
Capital/Financing Update
2025-01-15 English
Partial Exercise of Option and End of Stabilisation Period 2 pages 184.2KB
Capital/Financing Update
2025-01-14 English
Daily Stabilisation Activity Report - 10 January 2025 1
Capital/Financing Update
2025-01-12 English
Daily Stabilisation Activity Report - 8 January 2025 1
Capital/Financing Update
2025-01-08 English
Daily Stabilisation Activity Report - 7 January 2025 1
Capital/Financing Update
2025-01-07 English
Statement of CDIs on issue - AVR 5 pages 19.6KB
Capital/Financing Update
2025-01-07 English
Daily Stabilisation Activity Report - 6 January 2025 1
Capital/Financing Update
2025-01-06 English
Daily Stabilisation Activity Report - 3 January 2025 1
Regulatory Filings
2025-01-05 English
Daily Stabilisation Activity Report - 2 Jan 2025 1
Capital/Financing Update
2025-01-02 English
Daily Stabilisation Activity Report - 31 December 2024 1
Capital/Financing Update
2025-01-01 English